ArticleFrontiers in medical technology2026
Augmenting medical image specific foundation model with classical radiomic signatures for improved nasopharyngeal carcinoma stage classification.
Article in Frontiers in medical technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate clinical staging is the critical process of prognosis and treatment planning for nasopharyngeal carcinoma (NPC). Conventional radiomics is limited to hand-crafted features that may overlook complex patterns, while generic deep learning models often lack domain specificity. Currently, SAM-Med3D, a vision transformer (ViT)-based medical model excels at capturing global volumetric context. We hypothesized that fusing radiomic and SAM-Med3D feature-extraction would yield synergistic value. This study aims to construct an MRI-based fusion model for NPC stage classification (Stage I, II and III vs. Stage IVa) and benchmark its performance against experienced experts. Methods: We retrospectively analyzed 264 patients with non-metastatic nasopharyngeal carcinoma, partitioned into training ( Results: LASSO regression identified an optimal fusion set of 17 features (9 hand-crafted and 8 deep-learned). Among all 15 constructed DL models, the fusion-based LR yielded the optimal performance (AUC = 0.760, optimism-corrected AUC of 0.836), and the fusion approaches consistently yielded higher AUCs than individual feature approaches. Compared to human experts, our optimal model achieved a more balanced performance (Sensitivity: 73.91% vs. 88%; Specificity: 69.77% vs. 26%-30%) and a higher F1-score (0.615 vs. 0.353-0.400). Conclusions: The integrated model, combining conventional radiomics with SAM-Med3D features, consistently showed higher accuracy than its unimodal counterparts across five distinct algorithms (LR, SVM, RF, XGB, LGBM) for NPC stage I, II, III and stage IVa differentiation. All five fusion models demonstrated comparable discriminative ability compared to experienced experts. These findings suggest that hybrid feature frameworks can serve as powerful objective tools in NPC staging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.